Fluent Sagitta Indica Dominant Vape Cartridge

(2 customer reviews)

$45.00$80.00

Relaxed Indica with Mild Sedation

Sagitta is an Indica strain produced from a hybrid Cannabis sativa and Cannabis indica plant and has a ratio of 40:1 THC:CBD. It is known for leaving patients feeling calm, uplifted and relaxed. It is best known for treating conditions such as insomnia, chronic stress, anxiety, bipolar disease and muscle spasms and tremors. Its high THC level is responsible for the alleviation of anxiety and replacement with a calm euphoria. Sagitta is a whole plant product that contains THC, CBD and the full range of other natural components found in Cannabis including terpenes, flavonoids and other cannabinoids that are believed to contribute the medicinal properties of Cannabis.

Current medical literature supports the use of THC rich products for the treatment of all conditions approved for medical cannabis.

Strain: Sensi Skunk

CBD Content: Approximately 1%

THC Content: Approximately 30% (300mg) & 60% (600mg)

THC to CBD Ratio: 40:1

Dosing Units: Each 300mg cartridge contains 1 mg THC/inhalation & 2 mg THC/inhalation for 600mg cartridge

Total Doses: Approximately 300 inhalations per cartridge

Sold By: Fluent

Categories: Vape Cartridges, Indica Dominant, Hybrid

Clear

2 reviews for Fluent Sagitta Indica Dominant Vape Cartridge

  1. Jeff

    I want to get this in flower so bad. I first started with this in a vape pen and it worked great and had that awesome taste i miss from back in the day. Great product but NEED SAGITA IN FLOWER !!!

  2. Gwen Miller

    Knox never has this item any more why?

Add a review

Your email address will not be published.

“Vaping” is short for “vaporization”. Effects are felt immediately and unlike smoking, no combustion or burning takes place. Portable vaporizers are very discreet, as vapor dissipates quickly with minimal odor.Patients are recommended to initiate treatment on the evening of Day 1 with 1-3 inhalation sessions. Each session consists of 1-2 draws that are relatively shallow (1-3 seconds) and held for about 5 seconds before exhaling.

After 5-10 minutes, patients reassess symptoms. If symptoms have improved or subsided, no additional sessions are needed and patients take the next dose on the morning of Day 2.

Relief for patients with chronic neuropathic pain who have not responded adequately to other pain medication.

Cash & CanPay Accepted

Sagitta® is contraindicated in patients:

• with hypersensitivity to cannabinoids (e.g., THC or CBD) or to any of the inert ingredients in Sagitta®;
• with a significant history of cardiovascular disease;
• with an active or previous psychotic or active mood or anxiety disorder; and
• who are pregnant, planning to become pregnant, or are breastfeeding.